Biopsy Core Number Represents One of Foremost Predictors of Clinically Significant Gleason Sum Upgrading in Patients With Low-risk Prostate Cancer

Model Selection and Model Averaging in Phylogenetics: Advantages of Akaike Information Criterion and Bayesian Approaches Over Likelihood Ratio Tests

David Posada, Thomas R. Buckley · Systematic Biology · 2004 · 4K citations · Full text

Life Sciences, Biology, Evolutionary Biology +17

Characteristics of insignificant clinical T1c prostate tumors

Patrick J. Bastian, Leslie A. Mangold, Jonathan I. Epstein et al. · Cancer · 2004 · 234 citations · Full text

Medicine, Surgery, Urology +17

Development and Internal Validation of a Nomogram Predicting the Probability of Prostate Cancer Gleason Sum Upgrading Between Biopsy and Radical Prostatectomy Pathology

Felix K.‐H. Chun, Thomas Steuber, Andreas Erbersdobler et al. · European Urology · 2005 · 215 citations

Medicine, Oncology, Urology +14

Extended 21-Sample Needle Biopsy Protocol for Diagnosis of Prostate Cancer in 1000 Consecutive Patients

Guillaume Guichard, S. Larré, Andrea Gallina et al. · European Urology · 2007 · 182 citations

Medicine, Oncology, Urology +16

Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men

Claudio Jeldres, Nazareno Suardi, Jochen Walz et al. · European Urology · 2007 · 135 citations

Medicine, Oncology, Urology +10